SBIR/STTR Research Award

Retinal Oximeter for Clinical Assessments

Award identifier 8999f3e7dbb4a1f28272937502614a6d86c2c6de09d42d41a532bb4a01aeb78fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$111,289

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
PHOTON INDUSTRIES
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): In this SBIR we propose to develop a retinal vessel oxygen saturation monitoring system for investigational and clinical use. Retinal oximetry has been the subject of intense research and development since Hickam et al published the first photographic means in 1963. Studies of the retinal circulation and oxygen saturation have implicated oxygen status in diseases of the retina, including vein occlusion, diabetic retinopathy, glaucoma and optic atrophy. Oximetry studies have shown impairment of retinal blood flow regulation in diabetes and improvement in retinal oxygenation by pan-retinal photocoagulation treatment for proliferative diabetic retinopathy. Recently, studies have used imaging oximetry technique to evaluate side effects of glaucoma medications on retinal oxygenation. Thus, there is growing interest in retinal oximetry for monitoring retinal pathology. We propose here to develop an instrument we call OXYCAM for determining changes in oxygenation from distinct regions of the retina. This ability to detect subtle changes will be important in preventing the blinding complications of retinovascular disease. The long-term objectives of this project are 1) to make available a standardized commercial system for oximetric evaluation of retinal disease in research institutions and clinics and 2) to determine the role of oximetry as a retinal evaluation tool, which will lead to a commercial market for oximetry products. The specific aims of Phase I include 1) development of the dual-wavelength OXYCAM Imaging system for oximetric assessment at different levels of the retinal circulation and 2) validation of the OXYCAM performance in normal subjects. Coverage of retinal vessel networks in single dual-wavelength recordings will be achieved with pairs of large-format CCD sensors and a dichroic image splitter. Our longer term aims in Phase II include 1) development of automated vessel tracking and oximetry analysis software, 2) refinement of oximetry technique to improve accuracy and reproducibility in clinical work and 3) multi-site investigations into the role of oximetry in diagnosis, management and treatment of retinal disease.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.